Oramed Pharmaceuticals, Inc.
(NASDAQ : ORMP)

( )
ORMP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
-0.05%84.0320.1%$620.21m
AMRNAmarin Corp. Plc
1.04%23.231.7%$277.84m
VRXValeant Pharmaceuticals International, Inc.
8.71%31.8914.1%$187.65m
ARQLArQule, Inc.
-1.04%19.990.6%$140.34m
SAGESAGE Therapeutics, Inc.
5.47%76.568.6%$136.29m
BHCBausch Health Cos., Inc.
8.71%31.890.0%$132.19m
ICPTIntercept Pharmaceuticals, Inc.
-2.87%115.9316.9%$94.12m
JAZZJazz Pharmaceuticals Plc
1.20%149.902.3%$91.82m
GWPHGW Pharmaceuticals Plc
2.74%105.706.2%$86.29m
PRGOPerrigo Co. Plc
1.36%54.546.8%$65.30m
AXSMAxsome Therapeutics, Inc.
1.04%48.572.0%$60.26m
HZNPHorizon Therapeutics Plc
1.83%32.846.6%$44.72m
ICLRICON plc
-0.10%161.574.2%$42.46m
UTHRUnited Therapeutics Corp.
1.37%93.7614.3%$36.17m
ENDPEndo International Plc
7.06%4.708.8%$33.53m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.